Articles tagged with Approval from Medical Marketing and Mediahttp://www.mmm-online.com/approval/topic/214/
Articles tagged with Approval from Medical Marketing and MediaMMMmmmsubs@haymarketmedia.comnoFive things for pharma marketers to know: Friday, February 2023andMe is back in the DTC game; Sanofi has named its new CEO; drug companies are contemplating a pay-for-performance sales model.http://www.mmm-online.com/five-things-for-pharma-marketers-to-know-friday-february-20/article/399294/
Fri, 20 Feb 2015 16:06:35 GMT23andMe is back in the DTC game; Sanofi has named its new CEO; drug companies are contemplating a pay-for-performance sales model.MMMFive things for pharma marketers to know: Friday, February 13FDA approves Eisai's thryoid cancer drug two months early, Gilead and Germany agree to a Sovaldi price cut, and Valeant looks set to make a bid for Salix.http://www.mmm-online.com/five-things-for-pharma-marketers-to-know-friday-february-13/article/398100/
Fri, 13 Feb 2015 16:12:17 GMTFDA approves Eisai's thryoid cancer drug two months early, Gilead and Germany agree to a Sovaldi price cut, and Valeant looks set to make a bid for Salix.MMMFive things for pharma marketers to know: Thursday, January 15Google teams up with PwC for DOD EHR project bid; FDA approves first weight-loss device since 2007; research says opioid abuse may be on the decline.http://www.mmm-online.com/five-things-for-pharma-marketers-to-know-thursday-january-15/article/392702/
Thu, 15 Jan 2015 17:17:55 GMTGoogle teams up with PwC for DOD EHR project bid; FDA approves first weight-loss device since 2007; research says opioid abuse may be on the decline.MMMFDA 2014 approvals outpace those of 2013The regulator noted in its early 2014 retrospective that it set a high mark for the number of approved rare disease drugs this year, and that insufficient information is the reason many breakthrough status requests get bounced.http://www.mmm-online.com/fda-2014-approvals-outpace-those-of-2013/article/388389/
Mon, 15 Dec 2014 18:45:00 GMTThe regulator noted in its early 2014 retrospective that it set a high mark for the number of approved rare disease drugs this year, and that insufficient information is the reason many breakthrough status requests get bounced.MMMFive things for pharma marketers to know: Friday, September 19Lilly's weekly GLP-1 shot is approved, BI expands its lung-cancer portfolio, GSK's China investigation closes, NY proposed Sovaldi triage and India imposed price limits on 36 new medicines.http://www.mmm-online.com/five-things-for-pharma-marketers-to-know-friday-september-19/article/372515/
Fri, 19 Sep 2014 14:54:35 GMTLilly's weekly GLP-1 shot is approved, BI expands its lung-cancer portfolio, GSK's China investigation closes, NY proposed Sovaldi triage and India imposed price limits on 36 new medicines.MMMMerck scores first US PD-1 approvalThe FDA approved the drug previously known as pembrolizumab, now known as Keytruda, for patients with unresectable or metastatic melanoma who have taken Bristol-Myers Squibb's Yervoy (ipilimumab).http://www.mmm-online.com/merck-scores-first-us-pd-1-approval/article/369834/
Thu, 04 Sep 2014 19:37:42 GMTThe FDA approved the drug previously known as pembrolizumab, now known as Keytruda, for patients with unresectable or metastatic melanoma who have taken Bristol-Myers Squibb's Yervoy (ipilimumab).MMMGSK drug gets aplastic anemia indicationPromacta was previously indicated for chronic immune thrombocytopenia.http://www.mmm-online.com/gsk-drug-gets-aplastic-anemia-indication/article/368432/
Wed, 27 Aug 2014 17:28:06 GMTPromacta was previously indicated for chronic immune thrombocytopenia.MMMFive things for pharma marketers to know: Monday, August 25Roche backs away from Chugai but embraces InterMune, Merck rumored on track to score first PD-1 approval, a new Ebola strain may have surfaced and JNJ scoops up experimental anti-TNF.http://www.mmm-online.com/five-things-for-pharma-marketers-to-know-monday-august-25/article/367847/
Mon, 25 Aug 2014 14:53:09 GMTRoche backs away from Chugai but embraces InterMune, Merck rumored on track to score first PD-1 approval, a new Ebola strain may have surfaced and JNJ scoops up experimental anti-TNF.MMMGSK Ellipta franchise expandsThe FDA has approved Arnuity Ellipta for asthma.http://www.mmm-online.com/gsk-ellipta-franchise-expands/article/367467/
Thu, 21 Aug 2014 17:25:17 GMTThe FDA has approved Arnuity Ellipta for asthma.MMMBiogen twice-monthly MS drug approvedPlegridy is the only pegylated beta-interferon drug approved for relapsing multiple sclerosis.http://www.mmm-online.com/biogen-twice-monthly-ms-drug-approved/article/366770/
Mon, 18 Aug 2014 17:24:12 GMTPlegridy is the only pegylated beta-interferon drug approved for relapsing multiple sclerosis.MMM